A detailed history of Allspring Global Investments Holdings, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 121,625 shares of ACAD stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121,625
Previous 108,838 11.75%
Holding current value
$1.79 Million
Previous $1.77 Million 5.83%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$15.14 - $19.14 $193,595 - $244,743
12,787 Added 11.75%
121,625 $1.87 Million
Q2 2024

Jul 26, 2024

BUY
$14.62 - $18.42 $730,883 - $920,852
49,992 Added 84.95%
108,838 $1.77 Million
Q1 2024

Apr 18, 2024

SELL
$17.79 - $30.86 $1.57 Million - $2.72 Million
-88,253 Reduced 60.0%
58,846 $1.09 Million
Q4 2023

Jan 25, 2024

BUY
$20.78 - $31.77 $457,326 - $699,194
22,008 Added 17.59%
147,099 $4.61 Million
Q3 2023

Oct 27, 2023

BUY
$20.84 - $33.47 $2.61 Million - $4.19 Million
125,091 New
125,091 $2.61 Million
Q2 2023

Jul 18, 2023

SELL
$17.8 - $25.65 $908,316 - $1.31 Million
-51,029 Reduced 57.33%
37,980 $909,000
Q1 2023

Apr 13, 2023

BUY
$16.32 - $20.92 $1.3 Million - $1.67 Million
79,670 Added 853.09%
89,009 $1.68 Million
Q4 2022

Jan 23, 2023

SELL
$14.2 - $18.63 $35,684 - $46,817
-2,513 Reduced 21.2%
9,339 $0
Q3 2022

Oct 26, 2022

BUY
$14.11 - $18.27 $818 - $1,059
58 Added 0.49%
11,852 $193,000
Q2 2022

Jul 25, 2022

SELL
$13.01 - $27.22 $656,562 - $1.37 Million
-50,466 Reduced 81.06%
11,794 $166,000
Q1 2022

May 02, 2022

BUY
$20.94 - $27.5 $70,128 - $92,097
3,349 Added 5.68%
62,260 $0
Q4 2021

Jan 28, 2022

BUY
$16.79 - $27.09 $989,115 - $1.6 Million
58,911 New
58,911 $1.37 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.